<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(1)</volume><submitter>Wen J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Early death remains a major factor in survival in APL. We aimed to analyze the risk factors for differentiation syndrome and early death in acute promyelocytic leukemia (APL).&lt;h4>Methods&lt;/h4>The clinical data of APL patients who were newly diagnosed at Mianyang Central Hospital from January 2013 to January 2022 were retrospectively analyzed.&lt;h4>Results&lt;/h4>Eighty-six newly diagnosed APL patients (37 males and 49 females) were included in this study. The median age was 46 (17-75) years. Sixty-one patients (70.9%) had low/intermediate-risk APL, and 25 patients (29.1%) had high-risk APL. The incidence of differentiation syndrome (DS) was 62.4%. The multivariate analysis showed that a peak white blood cell (WBC) count ≥16 × 10^9/L was an independent risk factor (OR = 11.000,</pubmed_abstract><journal>BMC cancer</journal><pagination>27</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9824944</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.</pubmed_title><pmcid>PMC9824944</pmcid><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Shi L</pubmed_authors><pubmed_authors>Wen J</pubmed_authors><pubmed_authors>Zhou Q</pubmed_authors><pubmed_authors>Liang X</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Xu F</pubmed_authors><pubmed_authors>Yue J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.</name><description>&lt;h4>Background&lt;/h4>Early death remains a major factor in survival in APL. We aimed to analyze the risk factors for differentiation syndrome and early death in acute promyelocytic leukemia (APL).&lt;h4>Methods&lt;/h4>The clinical data of APL patients who were newly diagnosed at Mianyang Central Hospital from January 2013 to January 2022 were retrospectively analyzed.&lt;h4>Results&lt;/h4>Eighty-six newly diagnosed APL patients (37 males and 49 females) were included in this study. The median age was 46 (17-75) years. Sixty-one patients (70.9%) had low/intermediate-risk APL, and 25 patients (29.1%) had high-risk APL. The incidence of differentiation syndrome (DS) was 62.4%. The multivariate analysis showed that a peak white blood cell (WBC) count ≥16 × 10^9/L was an independent risk factor (OR = 11.000,</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-26T05:59:25.531Z</modification><creation>2025-04-06T11:43:58.735Z</creation></dates><accession>S-EPMC9824944</accession><cross_references><pubmed>36611025</pubmed><doi>10.1186/s12885-022-10499-2</doi></cross_references></HashMap>